What is happening. Beta-blockers, including nebivolol, can inhibit CoQ10-dependent enzymes and may lower endogenous CoQ10 levels (a recognized class effect, best characterized with propranolol). Supplemental CoQ10 is generally well tolerated alongside nebivolol, but because CoQ10 may modestly lower blood pressure on its own, the combination can produce additive blood-pressure reduction in some patients.
Mechanism. Beta-blockers inhibit CoQ10-dependent mitochondrial enzymes and may reduce circulating CoQ10. CoQ10 itself can have a mild antihypertensive effect via improved endothelial function and reduced oxidative stress, which can add to nebivolol's blood-pressure-lowering action.
Recommendation. Co-administration is reasonable and may help offset beta-blocker-related CoQ10 depletion, but monitor blood pressure and heart rate, especially when starting CoQ10 or adjusting the nebivolol dose. Report dizziness, lightheadedness, or unusual fatigue to the prescriber.